Effects of quadrivalent human papillomavirus vaccination.
Mauri
Davide
D
Polyzos
Nikolaos P
NP
D003362:Cost-Benefit Analysis; D019049:Developed Countries; D003906:Developing Countries; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D053918:Papillomavirus Vaccines; D015995:Prevalence; D002578:Uterine Cervical Dysplasia / Q000453:epidemiology / Q000473:pathology / Q000517:prevention & control*
D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines